Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
51%
Non-Hodgkin Lymphoma
49%
B Cell
41%
Follicular Lymphoma
38%
Neoplasm
36%
B-Cell Lymphoma
33%
Burkitt's Lymphoma
29%
Disease
28%
Mantle Cell Lymphoma
23%
Diagnosis
22%
Morphology
21%
Immunoglobulin
18%
Overall Survival
17%
Gene Expression
16%
MALT Lymphoma
16%
Biopsy
15%
Large-Cell Lymphoma
15%
Tumor Cell
12%
Fluorescence in Situ Hybridization
12%
Southern Blotting
12%
Radiation Therapy
12%
Prognostic Factor
12%
Bone Marrow Biopsy
11%
Sjoegren Syndrome
11%
Immunohistochemistry
11%
Cyclin D1
10%
Lymphoma Cell
10%
Follicle
10%
Cancer
10%
Malignant Neoplasm
9%
Protein Expression
9%
Protein P53
9%
Clinical Study
9%
Acute Myeloid Leukemia
9%
Allele
9%
Polymerase Chain Reaction
9%
Germinal Center
9%
Disease Course
8%
Multiple Myeloma
8%
International Prognostic Index
8%
Aplastic Anemia
8%
Elderly Patient
8%
Systemic Mastocytosis
8%
Laryngeal Cancer
8%
Disease Free Survival
7%
Central Nervous System
7%
Immunoglobulin M
7%
Plasma Cell
7%
Immunoglobulin Heavy Chain
7%
Lymphoblastic Lymphoma
7%
Immunology and Microbiology
B Cell
100%
Germinal Center
21%
Lymphoma Cell
17%
Central Nervous System
16%
Human Leukocyte Antigen
15%
Lymph Node
12%
Tumor Cell
12%
T Cell
11%
Cyclin D1
11%
Myeloid
11%
Gene Expression
10%
Fluorescence in Situ Hybridization
10%
Intravenous Immunoglobulin
10%
Cell Line
10%
Immunoglobulin Heavy Chain
9%
Epstein Barr Virus
9%
Overall Survival
9%
Allele
9%
Bcl-2
8%
Southern Blotting
8%
Amplicon
8%
Testis
7%
Chromosome Translocation
7%
Gene Rearrangement
6%
Cytotoxic T Cell
6%
SCID Mouse
6%
CD4
6%
Monospecific Antibody
6%
Plasma Cell
6%
CD8
6%
Polymerase Chain Reaction
5%
Monoclonal Antibody
5%
Mastocytosis
5%
Aplastic Anemia
5%
Heavy Chain
5%
Mouse
5%
Heterozygosity
5%
Keyphrases
Cyclin D1 (CCND1)
13%
Mantle Cell Lymphoma
12%
Lymphoma
12%
Non-Hodgkin Lymphoma
8%
B Cells
8%
Burkitt Lymphoma
8%
Cortactin
8%
B-cell Lymphoma 2 (Bcl-2)
8%
Follicular Lymphoma
7%
B-cell Lymphoma
7%
Fluorescence in Situ Hybridization
7%
DNA Fiber
6%
Acute Myeloid Leukemia
6%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
6%
Southern Blotting
6%
Population-based Registry
6%
B Cell Lines
6%
Double-color
6%
Immunophenotyping
6%
Hairy Cell Leukemia
5%
Bone Marrow
5%
Granzyme B
5%
Aggressive non-Hodgkin Lymphoma
5%
Hodgkin Disease
5%
Netherlands
5%
Laryngeal Carcinoma
5%
Cooperative Group
5%
Non-Hodgkin
5%
Gene Expression
5%
Terrein
5%
Veld
5%
Fas-associated Death Domain
5%
Poor Risk
5%
Acute Lymphoblastic Leukemia
5%
